New hope for advanced tumors? first human trial of XTX301 begins
Disease control
Recruiting now
This study tests a new drug, XTX301, in people with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. About 358 participants will take part in this early-phase trial across multiple centers…
Phase: PHASE1, PHASE2 • Sponsor: Xilio Development, Inc. • Aim: Disease control
Last updated May 17, 2026 00:45 UTC